An asset purchase agreement has been signed with Dexcel Pharma USA, which will acquire the full rights to Zubsolv® in the US, at a purchase price of USD 91 million plus the value of inventory at closi ...
The group’s biggest claims were largely incorrect, a New York Times analysis found. And its many smaller cuts added up to few ...
Life is hectic, and juggling dozens of apps for the "must-do" chores adds to the noise. Since I already work in Excel daily, ...